IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Revelation Biosciences Inc (REVB)

CUSIP: 76135L804 | NYSE | 16 institutional holders

Quarters

Q3 2026Q2 2026Q1 2026Q4 2025
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile

Beneficial Ownership — 13D / 13G

Full history →

5%+ stakes reported outside the quarterly cycle. A 13D is due within five business days of the event below, so these figures lead the holders table until the filer's next 13F catches up to them.

HolderShares% of ClassChangeEvent Datevs 13F
13G/AArmistice Capital, LLC209,2125.0%Newly reportedJun 30, 2026No 13F filer matched
13G/AArmistice Capital, LLC209,212
5.0% of class · Jun 30, 2026

Institutional Holders — Q3 2026

Citigroup Inc6
0.0% of portfolio›$5
Caitong International Asset Management Co., Ltd1
0.0% of portfolio›$1
StyleTurnoverLocationFiled
Citigroup Inc
6$50.0%CoreMediumNew York, NY2026-11-04
Caitong International Asset Management Co., Ltd
1$10.0%GrowthVery HighHong Kong, South Korea2026-10-29
Newly reported
No 13F filer matched